SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

Flu vaccine does not reduce risk of severe complications

By Leave a Comment

Food Consumer

09/11/2010

Editor’s note: For your information, food consumer is the first to report the study.

Italian researchers have discovered that the influenza vaccine does NOT reduce risk of severe complications from influenza viral infections that result in hospital death, influenza or pneumonia admission among the elderly population.

The finding came after Manzoli L. and colleagues from the University G. d’Annunzio of Chieti in Italy examined data from 32,457 elderly people, of whom 66.2 percent received the influenza vaccine.

According to a recent review, almost all flu vaccine trials, with the exception of one out of 49 of said trials, have not compared the incidence of flu in the vaccinated population with that in those unvaccinated.

Rather, subjects who received flu shots in influenza vaccine trials were only tested for antigens which were produced in response to flu vaccine. When a flu vaccine generated certain levels of antigens as defined by researchers, the vaccine maker claimed that the flu vaccine worked to prevent flu.

Pediatricians: Mandate flu shots

By Leave a Comment

Group is the latest to support vaccinating all health workers

By Steve Sternberg
September 8, 2010
USA TODAY

The American Academy of Pediatrics plans to call for all health workers to get flu vaccinations, saying unvaccinated doctors, nurses and other medical staffers pose a threat to patients.

The academy, which represents 60,000 pediatricians, is the latest of several organizations that now back mandatory flu shots for health workers. The groups include the National Patient Safety Foundation, the Infectious Diseases Society of America and the Society of Healthcare Epidemiologists.

Reports summarize human papillomavirus research from University of Michigan

By 1 Comment

NewsRx

September 6, 2010

Investigators publish new data in the report ‘Examining future adolescent human papillomavirus vaccine uptake, with and without a school mandate.’ In this recent report published in the Journal of Adolescent Health, researchers in the United States conducted a study “To develop a model of adolescent (HPV) human papillomavirus vaccine utilization that explored future HPV vaccination rates, with and without a school mandate, for the vaccine at middle school entry. A dynamic, population-based, compartmental model was developed that estimated over a 50-year time horizon HPV vaccine uptake among female adolescents living in the United States.”

Vaccine suspensions and drug disasters has made 2010 a annus horribilis for Glaxo Smith Kline

By Leave a Comment

American Chronicle

by Christina England
September 7, 2010

GlaxoSmithKline the drug giants, have spent the last few days trying to stay off the bottom of the FTSE 100, especially after the UK’s Medicines and Healthcare Products Regulatory Agency said that it’s diabetes treatment Avandia should be pulled from sale, over concerns that it can lead to heart attacks in some patients. This came at a particularly difficult time for GlaxoSmithKline and was yet another nail in their coffin, as Pandemrix, their vaccine for the swine flu, is currently also under the magnifying glass, having been suspended by Finland, Sweden, Poland and Nepal, due to a growing number of reports of adverse reactions.

Last night the UK documentary series Panorama, revealed that despite warnings that the drug Avandia should be removed from the market, millions of prescriptions for the drug were still being written every day and doctors had been ignoring the advice given, by failing to warn patients about potential safety issues. The safety trials which had been studied by the agencies approving the drug, were shown to be substandard and it was revealed that it was GSK themselves who had carried out the safety trials showing only the ones that boosted favourable results. These revelations appeared to have caused GSK to finally hit the bottom of the FTSE with a massive thud, as shares plummeted 19.5p to 1,249p. This was despite their insistence as usual that both Avandia and Pandemrix were both safe and effective.

Irish Media Choose their "Child Vaccine Scandal"

By 1 Comment

ComeLook.org, 29 August 2010

In Ireland, apparently, a story only qualifies as a ‘Vaccine Scandal’ if it relates to a ‘trial’ vaccine, preferably from 40-50 years ago, and the words ‘vaccine’ and ‘injury’ are not associated in any way.

Last weekend saw saturation coverage on a ‘Child Vaccine Scandal’ from the early 1960’s involving vaccine trials carried out without parental consent in Irish church-run children’s homes.

The Irish Independent ran three articles over four days (here, here, and here).
The Irish Times also ran two front page pieces on the same weekend (here and here).

The articles were triggered by the revelation that a number of victims, who now live in the US, are preparing a class action suit in the US courts (against the Pharma company responsible for the drug trials) because repeated attempts to seek justice in Ireland have failed.

News

Videos

Contact